These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12601530

  • 21. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E, Sabuncu T, Ozer EM, Hatemi H.
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [Abstract] [Full Text] [Related]

  • 22. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients].
    Zhang C, Zhou ZG, Lin J, Huang G, Wang JP, Zhang DM, Zhou M, Yang XL.
    Zhonghua Yi Xue Za Zhi; 2008 Mar 25; 88(12):797-801. PubMed ID: 18756979
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G, Auinger M, Clodi M, Prischl F, Kramar R, Diabetic Nephropathy Study Group of the Austrian Society of Nephrology.
    Nephrol Dial Transplant; 2005 Mar 25; 20(3):559-65. PubMed ID: 15671073
    [Abstract] [Full Text] [Related]

  • 24. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E, Ocenásová A, Straková J, Mokán M.
    Vnitr Lek; 1999 Feb 25; 45(2):97-102. PubMed ID: 15641228
    [Abstract] [Full Text] [Related]

  • 25. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE, Kusters GC, Netea MG, Netten PM.
    Neth J Med; 2006 Apr 25; 64(4):114-8. PubMed ID: 16609158
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults.
    Zhou Z, Ouyang L, Peng J, Yang W, Wang J, Zhu X, Wu H, Dyrberg T.
    Chin Med J (Engl); 1999 Jun 25; 112(6):554-7. PubMed ID: 11601338
    [Abstract] [Full Text] [Related]

  • 28. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, Todd I.
    Diabet Med; 2005 Apr 25; 22(4):448-52. PubMed ID: 15787671
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N.
    Immunol Lett; 2005 Jul 15; 99(2):180-5. PubMed ID: 16009268
    [Abstract] [Full Text] [Related]

  • 31. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E, Hallengren B, Agardh CD.
    Diabetes Metab Res Rev; 2004 Jul 15; 20(2):158-64. PubMed ID: 15037992
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?
    Reinehr T, Schober E, Wiegand S, Thon A, Holl R, DPV-Wiss Study Group.
    Arch Dis Child; 2006 Jun 15; 91(6):473-7. PubMed ID: 16449253
    [Abstract] [Full Text] [Related]

  • 34. [Expression of autoantibodies to ICA512 and GAD in the sera of patients with diabetic ketoacidosis or ketonemia].
    Zhang YJ, Chen HL, Yu LP, Han XY.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec 28; 25(6):545-7. PubMed ID: 12516400
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
    Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TM.
    Diabet Med; 2008 Oct 28; 25(10):1245-50. PubMed ID: 19046207
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J, Bárová H, Hill M, Masek Z.
    Vnitr Lek; 2002 Jun 28; 48(6):490-9. PubMed ID: 12132349
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
    Li X, Huang G, Yan X, Yang L, Zhou ZG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun 28; 30(6):1247-9. PubMed ID: 20584648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.